Gram Positive Bacteria
Lysozyme is an enzyme that breaks down bacterial cell walls, primarily targeting Gram-positive bacteria.
Gram-Positive Bacteria
- Complexity : Gram-positive bacteria have a simpler and more robust cell wall compared to Gram-negative bacteria, characterized by multiple layers of peptidoglycan.
- Teichoic Acid :Exists in two forms:
- Wall Teichoic Acids : Extend partway through the peptidoglycan layer.
- Lipoteichoic Acids : Extend completely through the wall and are anchored to the plasma membrane.
- Both forms protrude from the surface, imparting a negative charge to the bacterial cell.
Gram-Positive Bacteria
- Facilitates colonization of the nasal epithelium, enhancing bacterial adherence.
- Can trigger an inflammatory response, contributing to disease progression.
What our notes say
- Lysozyme is an enzyme that breaks down bacterial cell walls, primarily targeting Gram-positive bacteria. (Immune System Protective Mechanism)
- Gram-Positive Bacteria:Characterized by a thick layer of peptidoglycan. (Bacteria)
- Complexity: Gram-positive bacteria have a simpler and more robust cell wall compared to Gram-negative bacteria, characterized by multiple layers of peptidoglycan. (Bacteria)
- It's bactericidal against Gram-positive bacteria, especially MRSA. (Basic Pharmacology - Study Guide)
- Gram-positive bacteria: Possess a thick peptidoglycan layer (murein) external to the cell membrane. (Microbial Metabolism, Structure, and Therapeutics)
- Endospores: Highly resistant, dormant structures formed by some Gram-positive bacteria (e.g., *Bacillus*, *Clostridium*) in response to adverse conditions. (Microbial Metabolism, Structure, and Therapeutics)
Study material on Gram Positive Bacteria
Practice questions on Gram Positive Bacteria
Which fluoroquinolone has markedly enhanced activity against gram positive bacteria and anaerobes?
- Ciprofloxacin
- Levofloxacin
- Norfloxacin
- Moxifloxacin
- , maintains gram-negative coverage, and gains anaerobic coverag
Answer: A. Moxifloxacin is a 4th generation fluoroquinolone with improved gram-positive coverage (including S. pneumoniae), maintains gram-negative coverage, and gains anaerobic coverage. This broader spectrum distinguishes it from earlier fluoroquinolones like ciprofloxacin. ---